The matrix platform successfully incorporated corticosteroids and NSAIDs—two major therapeutic drug classes routinely used after cataract surgery. The results support the technical feasibility of ...
Development plan positions OcuRing™-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback